arrow-left

Board of Shukra Pharmaceuticals approves change in CEO and appointment of director

  • capital market |
  • 12 May, 2020 |
  • 12:00 AM
  • Board of Shukra Pharmaceuticals approves change in CEO and appointment of director
The Board of Shukra Pharmaceuticals at its meeting held on 11 May 2020 has approved the appointment of Mehul Patel as Chief Financial Officer [KMPJ of the Company. The Board has also appointed Ashvin Trivedi [DIN: 032L2457) as an additional Non-executive director of the Company. Further, the Board has accepted and taken note of Resignation of Karnik Shah as Chief Executive Officer [CEO) of the Company,

Invest wise with Expert advice

  • Open Demat with exclusive Advice & Services
  • Get a dedicated Relationship Manager to help you grow your wealth
  • Exclusive advisory on 20+ trading & wealth based investment options
  • One tap Investments, Automated trading & much more
ad IconAd Image

Most Read News

Article Image
  • 14 March, 2022 |
  • 7:03 AM

The US Federal committee's meeting will conclude on March 16, 2022.

Most Shared News

No Record Found